Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes
NHS hospitals in England used £19,789,923 of indicative cost of Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 20.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| North West Anglia Nhs Foundation Trust | £1,296,630 |
| Leeds Teaching Hpls Nhs Trust | £596,496 |
| Sheffield Teaching Hospitals Nhs Trust | £462,952 |
| Barts Health Nhs Trust | £462,267 |
| Western Sussex Hospitals Nhs Found Trust | £439,667 |
| Aintree University Hospital Nhs Ft | £430,080 |
| Royal Cornwall Hospitals Nhs Trust | £393,555 |
| Ruh Bath Nhs Foundation Trust | £351,551 |
| Derby Teaching Hospitals Nhs Found Trust | £333,289 |
| United Lincolnshire Hospitals Nhs Trust | £332,376 |
The primary-care picture
Tocilizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Tocilizumab medicine page.